237 related articles for article (PubMed ID: 19891966)
1. Activated protein C enhances cell motility of endothelial cells and MDA-MB-231 breast cancer cells by intracellular signal transduction.
Gramling MW; Beaulieu LM; Church FC
Exp Cell Res; 2010 Feb; 316(3):314-28. PubMed ID: 19891966
[TBL] [Abstract][Full Text] [Related]
2. Activated protein C promotes breast cancer cell migration through interactions with EPCR and PAR-1.
Beaulieu LM; Church FC
Exp Cell Res; 2007 Feb; 313(4):677-87. PubMed ID: 17254565
[TBL] [Abstract][Full Text] [Related]
3. Protein C and its inhibitor in malignancy.
Suzuki K; Hayashi T
Semin Thromb Hemost; 2007 Oct; 33(7):667-72. PubMed ID: 18000793
[TBL] [Abstract][Full Text] [Related]
4. ADAM17 promotes breast cancer cell malignant phenotype through EGFR-PI3K-AKT activation.
Zheng X; Jiang F; Katakowski M; Zhang ZG; Lu QE; Chopp M
Cancer Biol Ther; 2009 Jun; 8(11):1045-54. PubMed ID: 19395875
[TBL] [Abstract][Full Text] [Related]
5. Localization of uPAR and MMP-9 in lipid rafts is critical for migration, invasion and angiogenesis in human breast cancer cells.
Raghu H; Sodadasu PK; Malla RR; Gondi CS; Estes N; Rao JS
BMC Cancer; 2010 Nov; 10():647. PubMed ID: 21106094
[TBL] [Abstract][Full Text] [Related]
6. RNAi-mediated downregulation of urokinase plasminogen activator receptor and matrix metalloprotease-9 in human breast cancer cells results in decreased tumor invasion, angiogenesis and growth.
Kunigal S; Lakka SS; Gondi CS; Estes N; Rao JS
Int J Cancer; 2007 Nov; 121(10):2307-16. PubMed ID: 17657740
[TBL] [Abstract][Full Text] [Related]
7. Arachidonic acid promotes migration and invasion through a PI3K/Akt-dependent pathway in MDA-MB-231 breast cancer cells.
Villegas-Comonfort S; Castillo-Sanchez R; Serna-Marquez N; Cortes-Reynosa P; Salazar EP
Prostaglandins Leukot Essent Fatty Acids; 2014 May; 90(5):169-77. PubMed ID: 24565443
[TBL] [Abstract][Full Text] [Related]
8. The ligand occupancy of endothelial protein C receptor switches the protease-activated receptor 1-dependent signaling specificity of thrombin from a permeability-enhancing to a barrier-protective response in endothelial cells.
Bae JS; Yang L; Manithody C; Rezaie AR
Blood; 2007 Dec; 110(12):3909-16. PubMed ID: 17823308
[TBL] [Abstract][Full Text] [Related]
9. A splice variant of CD99 increases motility and MMP-9 expression of human breast cancer cells through the AKT-, ERK-, and JNK-dependent AP-1 activation signaling pathways.
Byun HJ; Hong IK; Kim E; Jin YJ; Jeoung DI; Hahn JH; Kim YM; Park SH; Lee H
J Biol Chem; 2006 Nov; 281(46):34833-47. PubMed ID: 16984917
[TBL] [Abstract][Full Text] [Related]
10. Activated protein C induces endothelial cell proliferation by mitogen-activated protein kinase activation in vitro and angiogenesis in vivo.
Uchiba M; Okajima K; Oike Y; Ito Y; Fukudome K; Isobe H; Suda T
Circ Res; 2004 Jul; 95(1):34-41. PubMed ID: 15166095
[TBL] [Abstract][Full Text] [Related]
11. Protease activated receptor 1 (PAR-1) activation by thrombin is protective in human pulmonary artery endothelial cells if endothelial protein C receptor is occupied by its natural ligand.
Bae JS; Rezaie AR
Thromb Haemost; 2008 Jul; 100(1):101-9. PubMed ID: 18612544
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E Receptor 2 Mediates Activated Protein C-Induced Endothelial Akt Activation and Endothelial Barrier Stabilization.
Sinha RK; Yang XV; Fernández JA; Xu X; Mosnier LO; Griffin JH
Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):518-24. PubMed ID: 26800564
[TBL] [Abstract][Full Text] [Related]
13. Blueberry phytochemicals inhibit growth and metastatic potential of MDA-MB-231 breast cancer cells through modulation of the phosphatidylinositol 3-kinase pathway.
Adams LS; Phung S; Yee N; Seeram NP; Li L; Chen S
Cancer Res; 2010 May; 70(9):3594-605. PubMed ID: 20388778
[TBL] [Abstract][Full Text] [Related]
14. Protective cross talk between activated protein C and TNF signaling in vascular endothelial cells: implication of EPCR, noncanonical NF-κB, and ERK1/2 MAP kinases.
Guitton C; Cottereau A; Gérard N; Quillard T; Chauveau A; Devallière J; Tonnerre P; Charreau B
Am J Physiol Cell Physiol; 2011 Apr; 300(4):C833-42. PubMed ID: 21228323
[TBL] [Abstract][Full Text] [Related]
15. Receptors of the protein C activation and activated protein C signaling pathways are colocalized in lipid rafts of endothelial cells.
Bae JS; Yang L; Rezaie AR
Proc Natl Acad Sci U S A; 2007 Feb; 104(8):2867-72. PubMed ID: 17299037
[TBL] [Abstract][Full Text] [Related]
16. Thrombin and activated protein C inhibit the expression of secretory group IIA phospholipase A(2) in the TNF-alpha-activated endothelial cells by EPCR and PAR-1 dependent mechanisms.
Bae JS; Rezaie AR
Thromb Res; 2010 Jan; 125(1):e9-e15. PubMed ID: 19683795
[TBL] [Abstract][Full Text] [Related]
17. 17β-Estradiol enhances breast cancer cell motility and invasion via extra-nuclear activation of actin-binding protein ezrin.
Zheng S; Huang J; Zhou K; Zhang C; Xiang Q; Tan Z; Wang T; Fu X
PLoS One; 2011; 6(7):e22439. PubMed ID: 21818323
[TBL] [Abstract][Full Text] [Related]
18. Formononetin inhibits migration and invasion of MDA-MB-231 and 4T1 breast cancer cells by suppressing MMP-2 and MMP-9 through PI3K/AKT signaling pathways.
Zhou R; Xu L; Ye M; Liao M; Du H; Chen H
Horm Metab Res; 2014 Oct; 46(11):753-60. PubMed ID: 24977660
[TBL] [Abstract][Full Text] [Related]
19. Occupancy of human EPCR by protein C induces β-arrestin-2 biased PAR1 signaling by both APC and thrombin.
Roy RV; Ardeshirylajimi A; Dinarvand P; Yang L; Rezaie AR
Blood; 2016 Oct; 128(14):1884-1893. PubMed ID: 27561318
[TBL] [Abstract][Full Text] [Related]
20. Gold nanoparticle-conjugated quercetin inhibits epithelial-mesenchymal transition, angiogenesis and invasiveness via EGFR/VEGFR-2-mediated pathway in breast cancer.
Balakrishnan S; Bhat FA; Raja Singh P; Mukherjee S; Elumalai P; Das S; Patra CR; Arunakaran J
Cell Prolif; 2016 Dec; 49(6):678-697. PubMed ID: 27641938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
